This bill updates the rules for testing new drugs by replacing animal testing references with nonclinical testing methods. It aims to speed up the drug approval process and encourage the use of alternative testing methods.
1. The bill requires the Secretary of Health and Human Services to create new rules for nonclinical testing methods within one year. 2. It replaces references to animal testing with nonclinical tests in various regulations to modernize drug approval processes. 3. The bill aims to improve the efficiency of drug development by allowing alternative testing methods. 4. It also includes a technical amendment related to clinical trial diversity plans.
This bill affects pharmaceutical companies, researchers, and patients seeking new treatments.